Forbion

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€200m

Latest public closing

5 Nov 2025

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Venture capital firm investing in biotech and other life-science companies.

Focus: Biopharmaceutical development across stages, plus BioEconomy (food, agriculture, materials, environmental technologies)

6 October 2026: announced a €2.3bn raise across two new funds, its largest ever (company post).